Procaps Group SA
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use… Read more
Market Cap & Net Worth: Procaps Group SA (PROC)
Procaps Group SA (NASDAQ:PROC) has a market capitalization of $124.11 Million ($124.11 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25736 globally and #8755 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Procaps Group SA's stock price $1.10 by its total outstanding shares 112824000 (112.82 Million).
Procaps Group SA Market Cap History: 2019 to 2025
Procaps Group SA's market capitalization history from 2019 to 2025. Data shows change from $1.11 Billion to $124.11 Million (-32.02% CAGR).
Procaps Group SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Procaps Group SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.11x
Procaps Group SA's market cap is 1.11 times its annual revenue
1.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
8.80x
Procaps Group SA's market cap is 8.80 times its annual earnings
9.89x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $1.11 Billion | $324.79 Million | -$17.01 Million | 3.42x | N/A |
| 2020 | $1.17 Billion | $331.47 Million | -$10.45 Million | 3.54x | N/A |
| 2021 | $1.10 Billion | $409.74 Million | -$100.86 Million | 2.68x | N/A |
| 2022 | $592.33 Million | $409.92 Million | $42.54 Million | 1.44x | 13.92x |
| 2023 | $459.19 Million | $414.10 Million | $52.20 Million | 1.11x | 8.80x |
Competitor Companies of PROC by Market Capitalization
Companies near Procaps Group SA in the global market cap rankings as of March 19, 2026.
Key companies related to Procaps Group SA by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Procaps Group SA Historical Marketcap From 2019 to 2025
Between 2019 and today, Procaps Group SA's market cap moved from $1.11 Billion to $ 124.11 Million, with a yearly change of -32.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $124.11 Million | -52.99% |
| 2024 | $264.01 Million | -42.51% |
| 2023 | $459.19 Million | -22.48% |
| 2022 | $592.33 Million | -46.15% |
| 2021 | $1.10 Billion | -6.25% |
| 2020 | $1.17 Billion | +5.58% |
| 2019 | $1.11 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Procaps Group SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $124.11 Million USD |
| MoneyControl | $124.11 Million USD |
| MarketWatch | $124.11 Million USD |
| marketcap.company | $124.11 Million USD |
| Reuters | $124.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.